Mit Stammzelltherapie being innovative and new, insurance may not cover the kosten at a center providing this kind of revolutionary treatment. The big pharma industry is still going very strong, and it’s a lot easier for doctors to simply prescribe some pills for the pain rather than taking a leap of faith with innovative therapies.

Kategorien: Stammzelltherapie

NBScience

Auftragsforschungsorganisation